NM_017849.4:c.3G>A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_ModeratePS1_ModeratePM2PP5_Very_Strong
The NM_017849.4(TMEM127):c.3G>A(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.0000021 in 1,426,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_017849.4 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM127 | NM_017849.4 | c.3G>A | p.Met1? | start_lost | Exon 2 of 4 | ENST00000258439.8 | NP_060319.1 | |
TMEM127 | NM_001193304.3 | c.3G>A | p.Met1? | start_lost | Exon 2 of 4 | NP_001180233.1 | ||
TMEM127 | NM_001407283.1 | c.-9+490G>A | intron_variant | Intron 1 of 2 | NP_001394212.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000157 AC: 2AN: 1274416Hom.: 0 Cov.: 31 AF XY: 0.00000160 AC XY: 1AN XY: 624168
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74354
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.M1? pathogenic mutation (also known as c.3G>A) is located in coding exon 1 of the TMEM127 gene and results from a G to A substitution at nucleotide position 3. This alters the methionine residue at the initiation codon (ATG). This mutation has been reported in multiple individuals with pheochromocytomas (PCC) (Bausch B et al. JAMA Oncol. 2017 Sep;3(9):1204-1212). This mutation has also been identified in the homozygous state in a Turkish patient with bilateral PCC (Eijkelenkamp K et al. Clin GEnet. 2018 May;93(5):1049-1056). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, sequence variations that modify the initiation codon are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Hereditary pheochromocytoma-paraganglioma Pathogenic:1
Experimental studies have shown that disruption of the initiator codon affects TMEM127 function (PMID: 21156949). This sequence change affects the initiator methionine of the TMEM127 mRNA. The next in-frame methionine is located at codon 85. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individuals with paraganglioma-pheochromocytoma syndrome (PMID: 28384794, 29282712; Invitae). ClinVar contains an entry for this variant (Variation ID: 532514). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at